Dr. Andrew Campbell is a graduate of Case Western Reserve University School of Medicine, Cleveland. He completed a pediatric residency at Massachusetts General Hospital, Boston, and a fellowship in hematology/oncology at Children's Memorial Hospital /Northwestern University, Chicago. Dr. Campbell joined the faculty of the University of Michigan in 2002 and serves as an attending physician in the Pediatric Comprehensive Sickle Cell Center. His clinical interests focus on sickle cell disease and thalassemia. Dr
‰ÛÏForced TR2/TR4 Expression in Sickle Cell Disease Mice Confers Enhanced Fetal Hemoglobin Synthesis and Alleviated Disease Phenotypes. Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18808-13.
Echocardiography-determined pulmonary hypertension and decline in exercise capacity over 22 months of follow-up in children and adolescents with sickle cell anemia.‰Û Haematologica, January;96(1) 33-40, 2011.
Angiogenic and Inflammatory Markers as Early Predictors of Cardiopulmonary Changes in Children and Adolescents with Sickle Cell Disease PLoS One Medicine Nov 23;4(11): e7956, 2009
Relationship of Erythropoietin, Fetal Hemoglobin, and Hydroxyurea use to Tricuspid Regurgitation Velocity in Children with Sickle Cell Disease‰Û Blood 114(21):4639-4644, 2009
Exploring the Attitudes of Ghanaian Women toward Genetic Testing for Sickle Cell Trait Int J Gynaecol Obstet. Int J Gynaecol Obstet. 2011 Dec;